I AM Jeffrey Cheah Professorial Fellow and Tutor in Medicine at Brasenose College, Oxford, and Professor of Virology at the Sir William Dunn School of Pathology, University of Oxford.
It has been my privilege, as a Jeffrey Cheah Fellow, to pay several academic visits to Sunway over the last few years to contribute to academic conferences, and to meet staff and students of the university.
By visiting Sunway one can immediately see what a visionary like Sunway Group founder and chairman Tan Sri Dr Jeffrey Cheah can achieve in a few decades.
Built on the site of a disused tin mine, a city has risen with shopping malls, shopping strips, hotels, residences, a theme park, a major hospital and an educational precinct, which has Sunway University as its centrepiece.
Although universities differ vastly in age, students remain always young. And, like their contemporaries in Oxford, they are smart, inquisitive and uncynical, so it is always a pleasure to visit.
I feel that there is an enormous pool of young talent in Malaysia that needs the opportunity for learning that outward-facing universities like Sunway can offer.
Tan Sri Dr Cheah's vision to engage with the most illustrious universities in the world, and his success in doing so is truly remarkable. My appointment as Jeffrey Cheah Professorial Fellow allows for all kinds of joint work between our two institutions.
In Brasenose College, through the Jeffrey Cheah Scholar-in-Residence programme, we have a stream of Sunway academics residing in Oxford each year, making connections and fostering the development of joint projects.
As a young university, Sunway will benefit greatly from the bonds of friendship with the oldest university in the UK and, dare I say, the top university in the world.
We are always willing to associate ourselves with Sunway in carrying out collaborative projects in areas of mutual expertise, which can bring renown to our respective institutions and to Malaysia.
Although best known for our work on the biology of HIV infection of macrophages, my lab has had a continuing interest in the biology of more exotic enveloped RNA viruses including dengue, Zika, and Bunyamwera viruses that from time to time cause serious outbreaks around the world, and which in principle could re-emerge as public health problems more widely.
At the beginning of 2020, we were very focused on using the stem cell-based technology we had developed for HIV research to investigate the genetic control of chronic inflammatory processes in both HIV-associated neurocognitive disease and in common neurodegenerative disorders.
As the pandemic began to take hold, however, we realised that our steam age virology expertise was in short supply in the UK and could make a significant contribution to the urgent search for effective new therapies and vaccines for Covid-19.
Accordingly, during March my colleagues and I began the process of reconfiguring the containment level III laboratory suite at the Sir William Dunn School of Pathology, which we had built for HIV research 25 years earlier, to handle the new coronavirus.
This rapid turnaround gained certification by the HSE over Easter, and we set about establishing standardised procedures for evaluating both new candidate drugs to treat Covid-19 infection, and antibodies to provide immunity to infection.
This was in no small measure made possible by generous contributions to the universitys rapid response fund by philanthropic donors. We have been able to recruit and train about a dozen scientists, whose research projects on other viruses had been temporarily suspended during the lockdown, to constitute dedicated teams to run each of these specialised procedures.
I have taken personal responsibility for the team evaluating the neutralising potency of antibodies and related molecules, and it has been very rewarding to be able to evaluate cutting-edge candidate molecules coming, not only from academic and clinical laboratories in Oxford and the Oxford region, but also from biotech companies as far apart as Colorado and Guangzhou.
In a very short time, we have been able to identify extremely promising candidates, the results of which are now already in the public domain, and which are being actively pursued for clinical development.
We have recently developed a new, high throughput technique, which will enable us to evaluate many more samples and recently began an exciting new phase in which we use the technique to investigate the quality of antibody responses made by participants in the first phase of the Oxford Covid-19 vaccine programme.
As lockdown eases, the scientists who have been seconded to the core virus facility are beginning to think once again about returning to their main research projects.
Accordingly, we are actively investigating ways in which we can put the core virology service on a more sustainable footing.
We are very conscious that the world remains vulnerable not only to second waves of SARS-CoV-2 but also to other as yet unidentified emerging viruses, and are determined to play our part in ensuring that future generations have the ability to respond rapidly and effectively.
About Prof William James
A Jeffrey Cheah Professororial Fellow Emeritus and Fellow in Medicine at Brasenose College, Oxford, Prof James is a virologist with a background in genetics and microbiology.
As the Professor of Virology with University of Oxford, he is the principal investigator at the Stem Cell Research Institute of Oxford, running a research lab studying HIV-macrophage biology using stem cell technology.
His research interest since the mid-1980s has been largely focused on the AIDS virus, HIV-1, particularly how it replicates in macrophages and how smart nucleic acids can be developed to prevent its replication.
He focuses on how stem cells can be used to rewrite the defence cells of the brain to make them resistant to HIV. It could one day provide insights into which drugs can be used to help slow down or prevent the neuro-degenerative effects of the virus.
He was also the University of Oxfords Pro Vice-Chancellor for Planning and Resource Allocation from 2011 to 2017.
More:
THE BONDS OF FRIENDSHIP: OXFORD AND SUNWAY - The Star Online
- Glowing embryonic gecko hand and otherworldly slime mold amaze in winning microscope photos - Livescience.com - October 13th, 2022
- Sierra Space, UC San Diego Partner to Develop the First Stem Cell Research Institute in Space - Business Wire - October 4th, 2022
- Second-Line BCL Treatment Landscape Shifts From ASCT to CAR T-Cell Therapy - Targeted Oncology - October 4th, 2022
- CellResearch Corporation reports positive results of DFU trial - Labiotech.eu - September 25th, 2022
- University of Colorado's ocular stem cell and regenerative research program recognized - Ophthalmology Times - September 8th, 2022
- RoosterBio and AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell and Exosome Therapies - GlobeNewswire - August 22nd, 2022
- Patient Profile 1: A 63-Year-Old Female with Relapsed Multiple Myeloma - OncLive - August 22nd, 2022
- Stem Cell Therapy: Update and Clinical Research 2022 - August 14th, 2022
- The engineer who teaches our bodies to heal themselves - EL PAS USA - July 19th, 2022
- Control in Healthcare: History and Reclamation of Bodily Autonomy - Non Profit News - Nonprofit Quarterly - July 19th, 2022
- This Simple Fish May Have Been One of the First Vertebrates - The Scientist - July 11th, 2022
- How Tumor Cells Use Mitochondria to Keep Growing - July 3rd, 2022
- Nearly 75 Percent Of Veterinarians Concerned That Frequent Injections Could Cause Joint Damage - Horse Racing News - Paulick Report - July 3rd, 2022
- OEDIT Announces Recipients of Collaborative Infrastructure Grant - Colorado Office of Economic Development and International Trade - June 22nd, 2022
- Politics Briefing: Conservative leadership race is intense, Bergen says, but she expects party unity once it's over - The Globe and Mail - June 13th, 2022
- Maine health care workers to appeal order to disclose their names in vaccine mandate lawsuit - Press Herald - June 4th, 2022
- America's return to the 19th century - York Dispatch - June 4th, 2022
- Top 10 Most Popular Stem Cell Treatments of 2022 - April 19th, 2022
- Will Smith's Slap at the Oscars Awakens the World to Alopecia Areata - University of Colorado Anschutz Medical Campus - April 19th, 2022
- Northern Colorado Doctor Researching New Treatment Options ... - December 24th, 2021
- Christmas Wish: 4-year-old just wants life-saving treatment for her twin brother - FOX 31 Denver - December 24th, 2021
- Breakthrough infections might not be a big transmission risk. Heres the evidence. - WBEZ - October 16th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Stem Cell Therapy Market Size, Top Key Players, Applications, Business Statistics, Trends and Forecast 2021-2027 The Bisouv Network - The Bisouv... - February 7th, 2021
- More on deadly blizzards | TheFencePost.com - Fence Post - February 7th, 2021
- 'A heart of gold': Rick Schwartz remembered for his commitment to family, community - CTV News - November 13th, 2020
- Alex Trebek died of pancreatic cancer think twice before saying he lost his battle with the disease - MarketWatch - November 13th, 2020
- Culprit Mutations, Risky (Neandertal) Variants, Genomic Analysis App: COVID-19 Updates - Bio-IT World - October 7th, 2020
- Stem Cell Therapy Market Size, Analytical Overview, Key Players, Growth Factors, Demand, Trends And Forecast to 2027 - thedailychronicle.in - September 30th, 2020
- Cancer Stem Cells Market is Thriving Worldwide 2020-2027 | Top Companies Merck KGaA, ONCOMED PHARMACEUTICALS INC, Bionomics, MacroGenics, Inc.,... - September 9th, 2020
- 27 De-Stressing Vegan Products to Help You Get Through The Rest of 2020 - VegNews - September 9th, 2020
- Colorados juvenile prisons have avoided COVID-19 outbreaks, but advocates worry about the future - The Denver Post - May 30th, 2020
- Future Leader Winner Using Technology To Solve The Problems He Sees - CBS Denver - May 30th, 2020
- SONDERMANN | Is it time to send a scientist to the Senate? - coloradopolitics.com - April 18th, 2020
- 5 Things to Know About Hemp-CBD In Pet Products - The Fresh Toast - April 18th, 2020
- Alone, together: Isolation in the name of health is familiar - Coloradoan - March 24th, 2020
- Stem Cell Therapy Colorado - thriveMD Denver & Vail, CO - March 20th, 2020
- Little Tissue, Big Mission: Beating Heart Tissues to Ride Aboard The ISS - Newswise - March 9th, 2020
- Denver Regenerative Medicine & Stem Cell Therapy - March 1st, 2020
- 5 most popular innovation stories in Houston this week - InnovationMap - January 5th, 2020
- Chiropractor Denver Announces Hormone Replacement Therapy Colorado Springs to Transform Life of Aging People - Press Release - Digital Journal - November 24th, 2019
- Cord Blood Banking Services Market size with global investment, top companies analysis, new business developments and forecast 2025 - Montana Ledger - November 16th, 2019
- Stem Cell Therapy - Boulder, Colorado | Boulder Biologics |Jason Glowney, MD | Stem Cells - Denver, Colorado | PRP | Regenerative Medicine | EPAT |... - May 20th, 2019
- Stem Cells and Hearing Loss - Sound Relief Hearing Center - May 1st, 2019
- Stem Cell Therapy - Boulder, Colorado | Boulder Biologics ... - April 20th, 2019
- Stem Cell Therapy for Joint Pain and Soft Tissue, Colorado - April 12th, 2019
- Stem Cells from Fat vs. Bone Marrow Best Sources for ... - April 7th, 2019
- CROM Stem Cell Therapy- Denver, Colorado - March 27th, 2019
- Gene expression in stem cells | Data Nuggets - March 7th, 2019
- Denver Stem Cell | Area's Leading Stem Cell Doctors - February 22nd, 2019
- Stem Cell Therapy - Colorado Springs Orthopaedic Group - January 16th, 2019
- Using Stem Cells to Treat Sepsis - Stem Cell Centers, Colorado - November 28th, 2018
- Stem Cell Fraud | Colorado Stem Cell Therapy - November 23rd, 2018
- Colorado Stem Cell Therapy | Home - October 1st, 2018
- FAQ | Colorado Stem Cell Therapy - October 1st, 2018
- Stem Cell Therapy | Spine & Joint Solutions - Colorado Springs - July 29th, 2018
- In Depth About Regenerative Therapy | Regen Colorado - July 25th, 2018
- Pepsi: Aborted Baby Cells in Drink Research | Colorado ... - July 15th, 2018
- Stem Cell Therapy in Colorado | Aspen Integrative Medicine - June 23rd, 2018
- Stem Cell Therapy Denver Colorado - Colorado Rehabilitation - June 18th, 2018
- Stem Cell PRP Therapy | Colorado Stem Cell Therapy - June 18th, 2018
- Stem Cell Therapy - Colorado Springs Orthopedics - October 14th, 2017
- Top Stem Cell Therapy Clinic in Vail & Denver, Colorado ... - September 25th, 2017
- 'Little Frankenstein,' conceived so Minnesota doctors could save sister, is now a happy teen - Minneapolis Star Tribune - June 25th, 2017
- What happens when scientists leave their labs to experiment with politics? - Los Angeles Times - June 21st, 2017
- Regenexx: injections soon will replace orthopedic surgery - Broomfield Enterprise - June 21st, 2017
- How a simple cheek swab can save a life - FOX31 Denver - June 4th, 2017
- Ground broken on new $US65 million facility at Colorado State University - Horsetalk - June 4th, 2017
- SpaceX to launch CU-built heart, bone health experiments to space station - CU Boulder Today - June 4th, 2017
- Translational Medicine Institute launched at Colorado State University - Source - June 4th, 2017
- Giraffe 'sneakers' in use at the Cheyenne Mountain Zoo! - KKTV 11 News - May 24th, 2017
- For the first time ever, researchers produced lab-grown blood stem cells - Colorado Springs Gazette - May 24th, 2017
- Chattanooga Student Surprised to be a Gift of Life Donor - WDEF News 12 - May 24th, 2017
- Is Autologous Heamatopoietic Stem Cell Transplantation Still Viable for MS? - LWW Journals - May 19th, 2017
- Stem Cell Transplants May Work for MS, Study Says - LWW Journals (blog) - April 20th, 2017
- 'Priming' protein boosts stem cell response to injury, promotes healing - FierceBiotech - April 20th, 2017
- Overcoming Opioids: The quest for less addictive drugs - Colorado Springs Gazette - April 20th, 2017
- Climbing mountains for cancer research - The Wilton Bulletin - April 20th, 2017
- Australian of the Year Alan Mackay-Sim on the advantage of being 'an interested scientist' - The Sydney Morning Herald - April 9th, 2017
- Northern Colorado Surgeon Releases Three Year Results of Bone Marrow Stem Cell Treatment - PR Web (press release) - April 5th, 2017